INTERFERON GAMMA DANS COMBINAISON AVEC UNE PUCE DE DIAGNOSTIC MEDICAL POUR UNE UTILISATION DANS LE TRAITEMENT AMÉLIORÉ LA FIBROSE PULMONAIRE IDIOPATHIQUE
The present invention relates to a novel pharmaceutical composition of compounds having the biological activity of interferon gamma (IFN-gamma) or pirfenidone in combination with a diagnostic array of candidate polynucleotides for the improved treatment of all forms of interstitial lung disease, in particular of idiopathic pulmonary fibrosis (IPF).